T2 Biosystems Presents Data on the Company’s T2MR® Technology for the Detection of the Bacteria that Causes Lyme Disease Directly from Whole Blood at Cold Spring Harbor Laboratory Conference on Diagnostic Tests for Lyme Disease
21 sept. 2016 16h01 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, announced that Tom Lowery,...